series-b
Stage
2
Investors
About
Acesion Pharma is a Danish biotech company developing drugs for the treatment of atrial fibrillation, a common cardiac arrhythmia. The company creates therapies by inhibiting SK ion channels to regulate cardiac rhythm.
Explore Acesion Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.